Lei Liu

An accomplished doctorate recipient, Lei harnesses his advanced knowledge of biotechnology, biological science and chemistry to assist clients with protecting their valuable innovations. Lei makes strides to understand his clients’ business objectives and to obtain intellectual property assets that have business value for them.

Lei drafts and prosecutes Canadian patent applications and coordinates the drafting and prosecution of patent applications worldwide. He counts among his clients pharmaceutical and biotechnology companies, research institutions, and universities. Lei also has experience in IP transactions, and assisting clients with IP due diligence, IP audits and IP–related agreements.

Lei’s doctoral studies focused on cardiovascular, obesity and atherosclerosis research. During his studies, Lei received multiple prestigious awards including the Merck Frosst Schering Award and the AstraZeneca Award for presentations delivered at the Canadian Lipoprotein Conference, as well as the Dr. Robert John Wilson Fellowship. He also took part in the Stroke, Cardiovascular, Obesity, Lipids, Atherosclerosis Research (SCOLAR) Training Program funded by the Canadian Institutes of Health Research.

Lei has co-authored "Patent Protection for Second Medical Uses: Canada Chapter" (Wolters Kluwer Law, September 26 2016) with Steven Garland and Daniel Davies of Smart Biggar, and "Patent Litigation 2018 – Canada” (Chambers Global Practice Guides, February 2018) with Steven Garland, Jeremy Want and Daniel Davies of Smart Biggar.